UK NICE Gives GSK's Lupus Drug Benlysta Final OK, But With Conditions
Executive Summary
The UK's HTA in final guidance is recommending GlaxoSmithKline PLC's Benlysta for treating systemic lupus erythematosus on condition that NHS England and Britain's biggest drug maker work together to collect further data to address uncertainties about the medicine's efficacy.